Skip to content

A Randomized Clinical Trial to Study Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects

A Randomized Clinical Trial to Study Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects - ketogenesis and glucose -dependent insulin secretion methodologies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35025
Enrollment
12
Registered
2010-04-06
Start date
2010-04-07
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anti-obesity anti-obesity

Interventions

None listed

Sponsors

Merck Sharp & Dohme (MSD)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18-45 years, BMI 27-35 kg/m2 (inclusive)

Exclusion criteria

Exclusion criteria: Suffering from: hepatitis B, cancer or HIV/Aids. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters blood in the 10 months preceding the start of the study.

Design outcomes

Primary

MeasureTime frame
Pharmacodynamics Pharmacokinetics Safety

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)